Transgene Biotek Balance Sheet Annual

BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs

2.77 -0.09 (-3.15%)Updated : 11 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	143.66	144.09	142.33	142.36
Cash Equivalents	0.06	0.02	0.00	0.00
Other Liabilities Total	115.22	115.22	115.40	115.57
Long Term Debt	6.80	6.10	5.08	4.95
Common Stock Total	75.77	75.77	75.77	75.77
Other Current Assets Total	0.92	0.94	1.06	1.00
Total Assets	143.66	144.09	142.33	142.36
Cash	0.00	0.26	0.01	0.00
Total Equity	8.38	10.03	10.71	11.37
Long Term Investments	0.09	0.10	0.10	0.10
Retained Earnings( Accumulated Deficit)	-67.39	-65.74	-65.06	-64.40
Total Common Shares Outstanding	7.58	7.58	7.58	7.58
Tangible Book Valueper Share Common Eq	0.24	0.46	0.55	0.63
Total Liabilities	135.28	134.06	131.62	130.99
Total Debt	17.14	14.52	14.00	13.11
Cashand Short Term Investments	0.06	0.28	0.01	0.00
Total Receivables Net	0.01	0.01	0.01	0.01
Notes Payable/ Short Term Debt	10.34	8.42	8.92	8.16
Accounts Receivable- Trade Net	0.01	0.01	0.01	0.01
Property/ Plant/ Equipment Total- Net	3.09	3.29	1.67	1.76
Total Current Liabilities	13.26	12.74	11.14	10.47
Total Inventory	0.03	0.03	0.03	0.03
Accounts Payable	0.07	1.59	0.20	0.23
Other Currentliabilities Total	2.85	2.73	2.02	2.08
Total Long Term Debt	6.80	6.10	5.08	4.95
Intangibles Net	6.54	6.55	6.55	6.56
Other Long Term Assets Total	0.00	0.00	-	0.00
Note Receivable- Long Term	132.90	132.90	132.90	132.90
period Length	0.00	0.00	0.00	0.00
Total Current Assets	1.03	1.26	1.11	1.04